English
UROLOGY

8th Dartford Flexible Cystoscopy Course

Friday - 20 May, 2022

09:00 - 16:30 GMT (UK)

6 CPD CREDITS AWARDED BY BAUS

The 8th Dartford Flexible Cystoscopy Course offers an invaluable day of education consisting of presentations in the morning followed by practical work on bladder models in the afternoon.

Course Highlights:
  • Anatomy and physiology of the lower urinary tract
  • Flexible cystoscopy
  • Complications and antibiotic prophylaxis
  • Tips and tricks
  • Equipment and setting up a flexible cystoscopy
  • Practical skills workshop
Who should attend?

Urologists, Gynaecologists, Nurses and other Health Care Professionals

Course Registration Fee

£125.00 p.p.

Location

Institute of Medical Sciences
Canterbury Christchurch University
Chatham Maritime, Kent, ME4 4UF

Meet the Course Chairman

Prof Sanjeev Madaan B&W
 
Professor Sanjeev Madaan, PhD, FRCS (Urol), FEBU

Darent Valley Hospital (DVH)
Dartford, UK

 

Prof Madaan is the lead clinician for the treatment of urological cancer at Darent Valley Hospital (DVH), Dartford. He is an expert laparoscopic & Robotic surgeon. He has performed more than 800 major cancer operations (including prostate, bladder and kidney). Prof Madaan is an expert advisor to NICE centre for Guidelines and was involved in writing latest prostate cancer guidelines published in 2019. He is chairman of Urology tumour group at Kent & medway cancer alliance. He is also lead for Urology cancer research in KSS (Kent, Surry & Sussex). He has been awarded national Bronze clinical excellence award and is winner of ‘DVH hospital innovation and improvement award 2015’ for his innovation and introduction of new services at DVH. He has active in teaching and is actively involved in the laparoscopic as well as flexible cystoscopy training. He is a visiting professor with Canterbury Christchurch University. Prof Madaan has published widely with over 80 peer-reviewed publications. His research interests include haematuria, superficial bladder cancer management, active surveillance for prostate cancer and prostate cancer survivorship.